Thrombolytic therapy for patients with acute myocardial infarction. Causes increasing the probability of not receiving thrombolytic therapy.
Intravenous thrombolysis is the most accessible and the most common form of reperfusion therapy. The aim of this study was to identify demographic, clinical and electrocardiographic factors, which based on published data and in patients included in the project Audit of diagnostic and therapeutic procedures in patients with acute myocardial infarction (AUDIT), increased the probability of not receiving thrombolytic therapy. In order to maximize the impact of thrombolytic therapy to reduce the case fatality rate associated with an acute myocardial infarction, we review, which a number of studies provide evidence on the usage of thrombolytic therapy in elder, women, patients with diabetes mellitus, bundle-branch block and after stroke. (Fig. 10, Ref. 52.).
Motovska
Z
Z
Department of Internal Medicine, Slovak University of Health, Bratislava, Slovakia. motovskaz@stonline.sk
Jurkovicova
O
O
Cagan
S
S
D006297:Health Services Accessibility; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D012307:Risk Factors; D015996:Survival Rate; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data*